Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., Oct. 01, 2024 ( GLOBE NEWSWIRE ) -- Wave Life Sciences Ltd. ( Nasdaq: WVE ) , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced today that it closed its previously announced underwritten public ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
5 %
|
|
STT
|
Neutral
|
5 %
|
|
WVE
|
Somewhat Bullish
|
26 %
|
